Jon Cuthbert

Bitcoin dropped below the key $70,000 level on Friday as geopolitical tensions and weak economic data from the United States triggered a sharp market sell-off.

Decidr AI Industries (ASX:DAI) entered into a strategic partnership with Singapore-based ICON Consulting Group to accelerate the integration of Agentic AI within the SAP ecosystem.

SkyCity Entertainment (ASX:SKC) is bracing for a legal battle as it faces potential class action proceedings regarding its online gambling operations in New Zealand.

Halozyme Therapeutics (NASDAQ:HALO) shares were in focus Friday after partner Johnson & Johnson secured U.S. regulatory approval for a subcutaneous combination therapy that significantly reduces the risk of disease progression in patients with relapsed multiple myeloma.

Hurco Companies (NASDAQ:HURC) reported a reduced net loss for the first quarter of fiscal 2026, finding a silver lining in a double-digit surge in domestic orders despite a dip in global sales.

Immuneering (NASDAQ:IMRX) has achieved a 64% overall survival rate at 12 months in an ongoing Phase 2a clinical trial for its lead drug candidate, atebimetinib, in combination with chemotherapy for patients with metastatic pancreatic cancer.

MarketWise (NASDAQ:MKTW) reported fourth-quarter and full-year 2025 results on Friday, highlighting a successful pivot toward higher-value products that drove billings and cash flow well above company guidance.

The AES Corp. (NYSE:AES) reported fourth-quarter and full-year 2025 results on Friday, significantly exceeding Wall Street’s bottom-line projections even as the company prepares to go private.

XRP funding rates on Binance have turned sharply negative, a market signal that has historically preceded short-term price rebounds in the token.

Core Scientific has secured a $500 million loan facility from Morgan Stanley, with an option to expand the financing to $1 billion to support its growing data center operations.